We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
-21.51%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$8.43B
AUM Growth
-$8.39B
(-50%)
Cap. Flow
-$5.17B
Cap. Flow
% of AUM
-61.29%
Top 10 Holdings %
Top 10 Hldgs %
10.82%
Holding
1,704
New
583
Increased
218
Reduced
300
Closed
598
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$109M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$89.4M |
| 3 |
JPMorgan Chase
JPM
|
+$82.7M |
| 4 |
Intel
INTC
|
+$73.6M |
| 5 |
Boston Scientific
BSX
|
+$72.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$193M |
| 2 |
RTX Corp
RTX
|
+$170M |
| 3 |
PNC Financial Services
PNC
|
+$126M |
| 4 |
ExxonMobil
XOM
|
+$121M |
| 5 |
Bank of America
BAC
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.11% |
| 2 | Technology | 13.97% |
| 3 | Financials | 13.54% |
| 4 | Consumer Discretionary | 12.99% |
| 5 | Industrials | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Shutterstock
SSTK
$217M
| $244K | ﹤0.01% |
+7,587
| New | +$303K |
|
|
ARNA
1027
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $244K | ﹤0.01% |
5,800
+142
| +3% | +$6.51K |
|
1028
Brookfield
BN
$111B
| $241K | ﹤0.01% |
+15,266
| New | +$314K |
|
1029
Takeda Pharmaceutical
TAK
$55.5B
| $241K | ﹤0.01% |
+15,844
| New | +$287K |
|
|
LCI
1030
DELISTED
Lannett Company, Inc.
LCI
| $241K | ﹤0.01% |
+8,668
| New | +$291K |
|
1031
PUT
Interactive Brokers
IBKR
$41.4B
| $237K | ﹤0.01% |
+22,000
| New | +$266K |
|
1032
Diageo
DEO
$52.8B
| $235K | ﹤0.01% |
1,850
-1,106
| -37% | -$166K |
|
|
TEF
1033
DELISTED
Telefonica
TEF
| $233K | ﹤0.01% |
62,998
-15,545
| -20% | -$76.9K |
|
1034
Full House Resorts
FLL
$84.3M
| $228K | ﹤0.01% |
182,100
+7,100
| +4% | +$18.6K |
|
|
TVRD
1035
Tvardi Therapeutics
TVRD
$22.1M
| $228K | ﹤0.01% |
+479
| New | +$260K |
|
|
SYKE
1036
DELISTED
SYKES Enterprises Inc
SYKE
| $227K | ﹤0.01% |
8,371
-191,886
| -96% | -$6.19M |
|
|
GLIBA
1037
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $225K | ﹤0.01% |
3,948
-6,553
| -62% | -$445K |
|
1038
Transocean
RIG
$6.39B
| $223K | ﹤0.01% |
191,946
+86,508
| +82% | +$338K |
|
1039
Fluor
FLR
$7B
| $222K | ﹤0.01% |
+32,152
| New | +$449K |
|
1040
SFL Corp
SFL
$1.61B
| $220K | ﹤0.01% |
23,191
-29,378
| -56% | -$364K |
|
1041
First Financial Bancorp
FFBC
$3.6B
| $217K | ﹤0.01% |
+14,583
| New | +$313K |
|
1042
Philips
PHG
$26.8B
| $216K | ﹤0.01% |
+6,757
| New | +$239K |
|
|
STMP
1043
DELISTED
Stamps.com, Inc.
STMP
| $213K | ﹤0.01% |
+1,634
| New | +$171K |
|
1044
OGE Energy
OGE
$9.71B
| $210K | ﹤0.01% |
6,841
-29,266
| -81% | -$1.18M |
|
1045
Live Oak Bancshares
LOB
$2.01B
| $209K | ﹤0.01% |
+16,745
| New | +$265K |
|
1046
Insperity
NSP
$2.05B
| $208K | ﹤0.01% |
+5,585
| New | +$396K |
|
1047
Neurogene
NGNE
$713M
| $207K | ﹤0.01% |
910
-4,127
| -82% | -$849K |
|
1048
GoPro
GPRO
$117M
| $205K | ﹤0.01% |
+78,411
| New | +$291K |
|
1049
Otter Tail
OTTR
$3.9B
| $204K | ﹤0.01% |
+4,587
| New | +$229K |
|
|
QVCGA
1050
DELISTED
QVC Group Inc Series A
QVCGA
| $203K | ﹤0.01% |
+684
| New | +$244K |
|
Similar funds
BC
Balyasny Asset Management's Q1 2020 Portfolio in Review
As of Q1 2020, Balyasny Asset Management held 1,704 positions worth $8.43B, down 50% from $16.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Balyasny Asset Management withdrew a net $5.17B in Q1 2020, closing 598 positions and reducing 300 holdings. Its most notable exit was American International, an estimated $193M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 10% a quarter earlier, followed by Technology and Financials.
Against the trend, Balyasny Asset Management opened a new position in Lowe's Companies worth $86M.
- Balyasny Asset Management's largest Q1 2020 buy was Lowe's Companies: 999,686 shares worth $86M.
- Balyasny Asset Management added most to Boston Scientific in Q1 2020, an estimated $72.4M increase.
- Balyasny Asset Management's biggest Q1 2020 reduction was ExxonMobil, cutting an estimated $121M.
- Balyasny Asset Management fully exited American International in Q1 2020, selling an estimated $193M.
- Balyasny Asset Management's ten largest holdings make up 11% of its $8.43B portfolio in Q1 2020.
- Balyasny Asset Management opened 583 new positions and closed 598 in Q1 2020.
- Balyasny Asset Management's portfolio value fell 50% quarter-over-quarter to $8.43B.
Based on Balyasny Asset Management's 13F filing for Q1 2020, filed 15 May 2020.